Polynovo Ltd (ASX:PNV) hit a new 52-week high during trading on Thursday . The company traded as high as A$2.41 ($1.71) and last traded at A$2.39 ($1.69), with a volume of 6079239 shares changing hands. The stock had previously closed at A$2.28 ($1.62).
The firm’s 50-day moving average price is A$1.80. The firm has a market cap of $1.48 billion and a price-to-earnings ratio of -448.00.
Polynovo Company Profile (ASX:PNV)
Polynovo Limited, a medical device company, designs, develops, and manufactures dermal regeneration solutions in Australia. The company focuses on the development and commercialization of medical devices using its NovoSorb technology in the treatment of burns, surgical wounds, and negative pressure wound therapy.
Read More: Futures Contract
Receive News & Ratings for Polynovo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polynovo and related companies with MarketBeat.com's FREE daily email newsletter.